The Efficacy and Safety of Salmeterol/Fluticasone Propionate vs Atropium/Albuterol in Patients COPD
Status:
Unknown status
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
To determine the efficacy and safety of Salmeterol/Fluticasone Propionate 50/500ug BID vs
Ipratropium/Albuterol 36/206ug QID in Chinese patients with moderate-to-severe Chronic
Obstructive Pulmonary Disease (COPD).
Phase:
Phase 4
Details
Lead Sponsor:
Fudan University
Collaborators:
Armed Police Medical college Affiliated Hospital Beijing Chao Yang Hospital Guangzhou First Municipal People’s Hospital Guangzhou First People's Hospital Henan Provincial Hospital Henan Provincial People's Hospital Liaoning Province North Hospital Liaoning Tumor Hospital & Institute Peking Union Medical College Hospital Peking University Third Hospital Qingdao University Shanghai Zhongshan Hospital The First Affiliated Hospital of Anhui Medical University The First Affiliated Hospital of Guangzhou Medical University The First Affiliated Hospital with Nanjing Medical University West China Hospital Xinqiao Hospital of Chongqing